Evidence map›Paper›PMID 41541732›Full record

ArticleHeart rhythm O22025

Real-world outcomes of left atrial appendage closure in very elderly compared with younger patients.

Adam Mohmand-Borkowski, Nora Glass, Tendoh Timoh, Peter L Friedman, Tomasz Rozmyslowicz

Abstract read
In one paragraph

Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Adam Mohmand-BorkowskiDepartment of Cardiology, Cape Cod Hospital, Hyannis, Massachusetts.
Nora GlassDepartment of Cardiology, Cape Cod Hospital, Hyannis, Massachusetts.
Tendoh TimohDepartment of Cardiology, Cape Cod Hospital, Hyannis, Massachusetts.
Peter L FriedmanDepartment of Cardiology, Cape Cod Hospital, Hyannis, Massachusetts.
Tomasz RozmyslowiczDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Left atrial appendage occlusion (LAAO) has become an attractive alternative to chronic anticoagulation in the very elderly with atrial fibrillation (AF). Data on the outcomes and usefulness of this procedure in this population are limited. Objective: The purpose of this study was to analyze the real-world outcomes of LAAO in the very elderly. Methods: The outcomes of LAAO implantation in very elderly patients aged ≥85 years (average 88.1 years) compared with those in younger patients aged <85 years (average 76.7 years), from a single hospital center serving one of the oldest communities in the United States, were retrospectively analyzed. Successful procedures (at implant), procedural complications, 45-day device-related readmission, device-related thrombus (DRT), stroke, and death within 1 year were examined. Results: A total of 342 LAAO device implantations were performed during the analysis period, with a high success rate of 98.5% and a very low major complication rate of 0.3%. There was no difference in the in-hospital outcomes or complication rates between the 2 groups. The ischemic stroke rate was 2.6% at 1 year and was not significantly different between the groups. The 1-year all-cause mortality was 14.6% in those aged ≥85 years as compared with 7.9% in those aged <85 years ( Conclusion: LAAO is as safe and effective in the very elderly as in the younger population and may be performed with a very low complication rate. There is a trend toward increased 1-year mortality in the very elderly.

Indexed as

Atrial fibrillationLeft atrial appendage occlusionMortalityStroke preventionVery elderly

Identifiers

PMID41541732
PMCPMC12800814

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.